Immunological relevance of the coevolution of IDO1 and AHR

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Jaronen, Merja ^a   Quintana, Francisco J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

2,3 dioxygenase; Aryl hydrocarbon receptor; Tryptophan 2,3 dioxygenase

Indexed keywords

ABC TRANSPORTER; ALPHA SYNUCLEIN; AROMATIC HYDROCARBON RECEPTOR; HEAT SHOCK PROTEIN 90; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; KYNURENIC ACID; KYNURENINASE; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; LONG CHAIN FATTY ACID; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

AUTOFLUORESCENCE; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL PROLIFERATION; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LIGAND BINDING; MOLECULAR EVOLUTION; NONHUMAN; SALMONELLA TYPHIMURIUM; SHORT SURVEY; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM;

EID: 84918787819     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00521     Document Type: Short Survey

References (105)

1. Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA. Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol (1993) 44:911-7.
2. Dolwick KM, Swanson HI, Bradfield CA. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Proc Natl Acad Sci U S A (1993) 90:8566-70. doi: 10.1073/pnas.90.18.8566
3. Hahn ME. Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact (2002) 141:131-60. doi:10.1016/S0009-2797(02)00070-4
4. Kazlauskas A, Poellinger L, Pongratz I. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J Biol Chem (1999) 274:13519-24. doi:10.1074/jbc.274.19.13519
5. Ma Q, Whitlock JP Jr. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem (1997) 272:8878-84. doi:10.1074/jbc.272.14.8878
6. Perdew GH. Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem (1988) 263:13802-5.
7. Quintana FJ, Sherr DH. Aryl hydrocarbon receptor control of adaptive immunity. Pharmacol Rev (2013) 65:1148-61. doi:10.1124/pr.113.007823
8. Cox MB, Miller CA III. Cooperation of heat shock protein 90 and p23 in aryl hydrocarbon receptor signaling. Cell Stress Chaperones (2004) 9:4-20. doi:10.1379/460.1
9. Fukunaga BN, Probst MR, Reisz-Porszasz S, Hankinson O. Identification of functional domains of the aryl hydrocarbon receptor. J Biol Chem (1995) 270:29270-8. doi:10.1074/jbc.270.49.29270
10. Ikuta T, Kobayashi Y, Kawajiri K. Phosphorylation of nuclear localization signal inhibits the ligand-dependent nuclear import of aryl hydrocarbon receptor. Biochem Biophys Res Commun (2004) 317:545-50. doi:10.1016/j.bbrc.2004.03.076
11. Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science (1992) 256:1193-5. doi:10.1126/science.256.5060.1193
12. Adachi J, Mori Y, Matsui S, Matsuda T. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicol Sci (2004) 80:161-9. doi:10.1093/toxsci/kfh129
13. Hao N, Lee KL, Furness SGB, Bosdotter C, Poellinger L, Whitelaw ML. Xenobiotics and loss of cell adhesion drive distinct transcriptional outcomes by aryl hydrocarbon receptor signaling. Mol Pharmacol (2012) 82:1082-93. doi:10.1124/mol.112.078873
14. Lo R, Matthews J. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq. Toxicol Sci (2012) 130:349-61. doi:10.1093/toxsci/kfs253
15. Murray IA, Morales JL, Flaveny CA, Dinatale BC, Chiaro C, Gowdahalli K, et al. Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity. Mol Pharmacol (2010) 77:247-54. doi:10.1124/mol.109.061788
16. Ohtake F, Fujii-Kuriyama Y, Kato S. AHR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem Pharmacol (2009) 77:474-84. doi:10.1016/j.bcp.2008.08.034
17. Ohtake F, Baba A, Fujii-Kuriyama Y, Kato S. Intrinsic AHR function underlies cross-talk of dioxins with sex hormone signalings. Biochem Biophys Res Commun (2008) 370:541-6. doi:10.1016/j.bbrc.2008.03.054
18. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H, et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature (2007) 446:562-6. doi:10.1038/nature05683
19. Davarinos NA, Pollenz RS. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J Biol Chem (1999) 274:28708-15. doi:10.1074/jbc.274.40.28708
20. Ma Q, Baldwin KT. 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AHR) by the ubiquitin-proteasome pathway. Role of the transcription activaton and DNA binding of AHR. J Biol Chem (2000) 275:8432-8. doi:10.1074/jbc.275.12.8432
21. Pollenz RS, Barbour ER. Analysis of the complex relationship between nuclear export and aryl hydrocarbon receptor-mediated gene regulation. Mol Cell Biol (2000) 20:6095-104. doi:10.1128/MCB.20.16.6095-6104.2000
22. Waller CL, McKinney JD. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem Res Toxicol (1995) 8:847-58. doi:10.1021/tx00048a005
23. Carlson DB, Perdew GH. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol (2002) 16:317-25. doi:10.1002/jbt.10051
24. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol (2003) 43:309-34. doi:10.1146/annurev.pharmtox.43.100901.135828
25. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol (1999) 56:784-90.
26. Savouret JF, Antenos M, Quesne M, Xu J, Milgrom E, Casper RF. 7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J Biol Chem (2001) 276:3054-9. doi:10.1074/jbc.M005988200
27. Peterson KJ, Butterfield NJ. Origin of the Eumetazoa: testing ecological predictions of molecular clocks against the Proterozoic fossil record. Proc Natl Acad Sci U S A (2005) 102:9547-52. doi:10.1073/pnas.0503660102
28. Peterson KJ, Lyons JB, Nowak KS, Takacs CM, Wargo MJ, McPeek MA. Estimating metazoan divergence times with a molecular clock. Proc Natl Acad Sci U S A (2004) 101:6536-41. doi:10.1073/pnas.0401670101
29. Butler RA, Kelley ML, Powell WH, Hahn ME, Van Beneden RJ. An aryl hydrocarbon receptor (AHR) homologue from the soft-shell clam, Mya arenaria: evidence that invertebrate AHR homologues lack 2,3,7,8-tetrachlorodibenzo-p-dioxin and beta-naphthoflavone binding. Gene (2001) 278:223-34. doi:10.1016/S0378-1119(01)00724-7
30. Emmons RB, Duncan D, Estes PA, Kiefel P, Mosher JT, Sonnenfeld M, et al. The spineless-aristapedia and tango bHLH-PAS proteins interact to control antennal and tarsal development in Drosophila. Development (1999) 126:3937-45.
31. Powell-Coffman JA, Bradfield CA, Wood WB. Caenorhabditis elegans orthologs of the aryl hydrocarbon receptor and its heterodimerization partner the aryl hydrocarbon receptor nuclear translocator. Proc Natl Acad Sci U S A (1998) 95:2844-9. doi:10.1073/pnas.95.6.2844
32. Jones LM, Rayson SJ, Flemming AJ, Urwin PE. Adaptive and specialised transcriptional responses to xenobiotic stress in Caenorhabditis elegans are regulated by nuclear hormone receptors. PLoS One (2013) 8:e69956. doi:10.1371/journal.pone.0069956
33. Huang X, Powell-Coffman JA, Jin Y. The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans. Development (2004) 131:819-28. doi:10.1242/dev.00959
34. Qin H, Powell-Coffman JA. The Caenorhabditis elegans aryl hydrocarbon receptor, AHR-1, regulates neuronal development. Dev Biol (2004) 270:64-75. doi:10.1016/j.ydbio.2004.02.004
35. Smith CJ, O'Brien T, Chatzigeorgiou M, Spencer WC, Feingold-Link E, Husson SJ, et al. Sensory neuron fates are distinguished by a transcriptional switch that regulates dendrite branch stabilization. Neuron (2013) 79:266-80. doi:10.1016/j.neuron.2013.05.009
36. Qin H, Zhai Z, Powell-Coffman JA. The Caenorhabditis elegans AHR-1 transcription complex controls expression of soluble guanylate cyclase genes in the URX neurons and regulates aggregation behavior. Dev Biol (2006) 298:606-15. doi:10.1016/j.ydbio.2006.07.017
37. de Bono M, Bargmann CI. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C. elegans. Cell (1998) 94:679-89. doi:10.1016/S0092-8674(00)81609-8
38. Aarnio V, Storvik M, Lehtonen M, Asikainen S, Reisner K, Callaway J, et al. Fatty acid composition and gene expression profiles are altered in aryl hydrocarbon receptor-1 mutant Caenorhabditis elegans. Comp Biochem Physiol C Toxicol Pharmacol (2010) 151:318-24. doi:10.1016/j.cbpc.2009.12.006
39. Boverhof DR, Burgoon LD, Tashiro C, Chittim B, Harkema JR, Jump DB, et al. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol Sci (2005) 85:1048-63. doi:10.1093/toxsci/kfi162
40. Sato S, Shirakawa H, Tomita S, Ohsaki Y, Haketa K, Tooi O, et al. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol Appl Pharmacol (2008) 229:10-9. doi:10.1016/j.taap.2007.12.029
41. Duncan DM, Burgess EA, Duncan I. Control of distal antennal identity and tarsal development in Drosophila by spineless-aristapedia, a homolog of the mammalian dioxin receptor. Genes Dev (1998) 12:1290-303. doi:10.1101/gad.12.9.1290
42. Sonnenfeld M, Ward M, Nystrom G, Mosher J, Stahl S, Crews S. The Drosophila tango gene encodes a bHLH-PAS protein that is orthologous to mammalian Arnt and controls CNS midline and tracheal development. Development (1997) 124:4571-82.
43. Kudo K, Takeuchi T, Murakami Y, Ebina M, Kikuchi H. Characterization of the region of the aryl hydrocarbon receptor required for ligand dependency of transactivation using chimeric receptor between Drosophila and Mus musculus. Biochim Biophys Acta (2009) 1789:477-86. doi:10.1016/j.bbagrm.2009.06.003
44. Struhl G. Spineless-aristapedia: a homeotic gene that does not control the development of specific compartments in Drosophila. Genetics (1982) 102:737-49.
45. Wernet MF, Mazzoni EO, Celik A, Duncan DM, Duncan I, Desplan C. Stochastic spineless expression creates the retinal mosaic for colour vision. Nature (2006) 440:174-80. doi:10.1038/nature04615
46. Kim MD, Jan LY, Jan YN. The bHLH-PAS protein spineless is necessary for the diversification of dendrite morphology of Drosophila dendritic arborization neurons. Genes Dev (2006) 20:2806-19. doi:10.1101/gad.1459706
47. Hahn ME, Karchner SI, Evans BR, Franks DG, Merson RR, Lapseritis JM. Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J Exp Zoolog A Comp Exp Biol (2006) 305:693-706. doi:10.1002/jez.a.323
48. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol (1996) 140:173-9. doi:10.1006/taap.1996.0210
49. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells (1997) 2:645-54. doi:10.1046/j.1365-2443.1997.1490345.x
50. Benedict JC, Lin TM, Loeffler IK, Peterson RE, Flaws JA. Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol Sci (2000) 56:382-8. doi:10.1093/toxsci/56.2.382
51. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci U S A (2000) 97:10442-7. doi:10.1073/pnas.190256997
52. Robles R, Morita Y, Mann KK, Perez GI, Yang S, Matikainen T, et al. The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. Endocrinology (2000) 141:450-3. doi:10.1210/endo.141.1.7374
53. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine AHR null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A (1996) 93:6731-6. doi:10.1073/pnas.93.13.6731
54. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJD, Astelbauer F, Miu J, et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene (2007) 396:203-13. doi:10.1016/j.gene.2007.04.010
55. Shimizu T, Nomiyama S, Hirata F, Hayaishi O. Indoleamine 2,3-dioxygenase. Purification and some properties. J Biol Chem (1978) 253:4700-6.
56. Takikawa O, Kuroiwa T, Yamazaki F, Kido R. Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem (1988) 263:2041-8.
57. Kudo Y, Boyd CA, Sargent IL, Redman CW. Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J Physiol (2001) 535:207-15. doi:10.1111/j.1469-7793.2001.00207.x
58. Pfefferkorn ER, Rebhun S, Eckel M. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J Interferon Res (1986) 6:267-79. doi:10.1089/jir.1986.6.267
59. Mackenzie SM, Brooker MR, Gill TR, Cox GB, Howells AJ, Ewart GD. Mutations in the white gene of Drosophila melanogaster affecting ABC transporters that determine eye colouration. Biochim Biophys Acta (1999) 1419:173-85. doi:10.1016/S0005-2736(99)00064-4
60. Sullivan DT, Bell LA, Paton DR, Sullivan MC. Genetic and functional analysis of tryptophan transport in Malpighian tubules of Drosophila. Biochem Genet (1980) 18:1109-30. doi:10.1007/BF00484342
61. Campbell BM, Charych E, Lee AW, Möller T. Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci (2014) 8:12. doi:10.3389/fnins.2014.00012
62. Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood (2009) 113:2394-401. doi:10.1182/blood-2008-07-144485
63. Liu X, Liu Y, Ding M, Wang X. Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells. Mol Med Rep (2011) 4:53-8. doi:10.3892/mmr.2010.395
64. Maby-El Hajjami H, Amé-Thomas P, Pangault C, Tribut O, DeVos J, Jean R, et al. Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase. Cancer Res (2009) 69:3228-37. doi:10.1158/0008-5472.CAN-08-3000
65. Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest (2007) 117:1147-54. doi:10.1172/JCI31178
66. Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res (2012) 72:5435-40. doi:10.1158/0008-5472.CAN-12-0569
67. Vogel CFA, Goth SR, Dong B, Pessah IN, Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun (2008) 375:331-5. doi:10.1016/j.bbrc.2008.07.156
68. Litzenburger UM, Opitz CA, Sahm F, Rauschenbach KJ, Trump S, Winter M, et al. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget (2014) 5:1038-51.
69. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med (2002) 196:459-68. doi:10.1084/jem.20020121
70. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol (2003) 24:242-8. doi:10.1016/S1471-4906(03)00072-3
71. Mellor AL, Keskin DB, Johnson T, Chandler P, Munn DH. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol (2002) 1950(168):3771-6. doi:10.4049/jimmunol.168.8.3771
72. Sznurkowski JJ, Zawrocki A, Emerich J, Sznurkowska K, Biernat W. Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests. Gynecol Oncol (2011) 122:307-12. doi:10.1016/j.ygyno.2011.04.050
73. Curti A, Trabanelli S, Onofri C, Aluigi M, Salvestrini V, Ocadlikova D, et al. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. Haematologica (2010) 95:2022-30. doi:10.3324/haematol.2010.025924
74. Curti A, Pandolfi S, Valzasina B, Aluigi M, Isidori A, Ferri E, et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood (2007) 109:2871-7. doi:10.1182/blood-2006-07-036863
75. Levina V, Su Y, Gorelik E. Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation. Clin Dev Immunol (2012) 2012:173029. doi:10.1155/2012/173029
76. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol (2010) 1950(185):3190-8. doi:10.4049/jimmunol.0903670
77. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science (2005) 310:850-5. doi:10.1126/science.1117634
78. Britan A, Maffre V, Tone S, Drevet JR. Quantitative and spatial differences in the expression of tryptophan-metabolizing enzymes in mouse epididymis. Cell Tissue Res (2006) 324:301-10. doi:10.1007/s00441-005-0151-7
79. Haber R, Bessette D, Hulihan-Giblin B, Durcan MJ, Goldman D. Identification of tryptophan 2,3-dioxygenase RNA in rodent brain. J Neurochem (1993) 60:1159-62. doi:10.1111/j.1471-4159.1993.tb03269.x
80. Yuasa HJ, Takubo M, Takahashi A, Hasegawa T, Noma H, Suzuki T. Evolution of vertebrate indoleamine 2,3-dioxygenases. J Mol Evol (2007) 65:705-14. doi:10.1007/s00239-007-9049-1
81. Miller CL, Llenos IC, Dulay JR, Barillo MM, Yolken RH, Weis S. Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis (2004) 15:618-29. doi:10.1016/j.nbd.2003.12.015
82. Minatogawa Y, Suzuki S, Ando Y, Tone S, Takikawa O. Tryptophan pyrrole ring cleavage enzymes in placenta. Adv Exp Med Biol (2003) 527:425-34. doi:10.1007/978-1-4615-0135-0_50
83. Suzuki S, Toné S, Takikawa O, Kubo T, Kohno I, Minatogawa Y. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem J (2001) 355:425-9. doi:10.1042/0264-6021:3550425
84. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature (2011) 478:197-203. doi:10.1038/nature10491
85. Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature (2014) 511:184-90. doi:10.1038/nature13323
86. DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, et al. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci (2010) 115:89-97. doi:10.1093/toxsci/kfq024
87. Siddiqui SS, Babu P. Kynurenine hydroxylase mutants of the nematode Caenorhabditis elegans. Mol Gen Genet (1980) 179:21-4. doi:10.1007/BF00268441
88. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol (1990) 215:403-10. doi:10.1016/S0022-2836(05)80360-2
89. Van der Goot AT, Nollen EAA. Tryptophan metabolism: entering the field of aging and age-related pathologies. Trends Mol Med (2013) 19:336-44. doi:10.1016/j.molmed.2013.02.007
90. Coburn C, Allman E, Mahanti P, Benedetto A, Cabreiro F, Pincus Z, et al. Anthranilate fluorescence marks a calcium-propagated necrotic wave that promotes organismal death in C. elegans. PLoS Biol (2013) 11:e1001613. doi:10.1371/journal.pbio.1001613
91. Coburn C, Gems D. The mysterious case of the C. elegans gut granule: death fluorescence, anthranilic acid and the kynurenine pathway. Front Genet (2013) 4:151. doi:10.3389/fgene.2013.00151
92. Van der Goot AT, Zhu W, Vázquez-Manrique RP, Seinstra RI, Dettmer K, Michels H, et al. Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation. Proc Natl Acad Sci U S A (2012) 109:14912-7. doi:10.1073/pnas.1203083109
93. Baillie DL, Chovnick A. Studies on the genetic control of tryptophan pyrrolase in Drosophila melanogaster. Mol Gen Genet (1971) 112:341-53. doi:10.1007/BF00334435
94. Tartof KD. Interacting gene systems: I. the regulation of tryptophan pyrrolase by the vermilion-suppressor of vermilion system in Drosophila. Genetics (1969) 62:781-95.
95. Tearle R. Tissue specific effects of ommochrome pathway mutations in Drosophila melanogaster. Genet Res (1991) 57:257-66. doi:10.1017/S0016672300029402
96. Roberts JE. Ocular phototoxicity. J Photochem Photobiol B (2001) 64:136-43. doi:10.1016/S1011-1344(01)00196-8
97. Beadle GW, Ephrussi B. Development of eye colors in Drosophila: transplantation experiments with suppressor of vermilion. Proc Natl Acad Sci U S A (1936) 22:536-40. doi:10.1073/pnas.22.9.536 Searles LL, Voelker RA. Molecular characterization of the Drosophila vermilion locus and its suppressible alleles. Proc Natl Acad Sci U S A (1986) 83:404-8. doi:10.1073/pnas.83.2.404
98. Searles LL, Voelker RA. Molecular characterization of the Drosophila vermilion locus and its suppressible alleles. Proc Natl Acad Sci U S A (1986) 83:404-8. doi:10.1073/pnas.83.2.404
99. Savvateeva-Popova EV, Popov AV, Heinemann T, Riederer P. Drosophila mutants of the kynurenine pathway as a model for ageing studies. Adv Exp Med Biol (2003) 527:713-22. doi:10.1007/978-1-4615-0135-0_84
100. Campesan S, Green EW, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, et al. The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. Curr Biol (2011) 21:961-6. doi:10.1016/j.cub.2011.04.028
101. Oxenkrug GF. The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine. J Neural Transm (2010) 1996(117):23-6. doi:10.1007/s00702-009-0341-7
102. Oxenkrug GF, Navrotskaya V, Voroboyva L, Summergrad P. Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan-kynurenine metabolism. Fly (Austin) (2011) 5:307-9. doi:10.4161/fly.5.4.18414
103. Savvateeva EV, Popov AV, Kamyshev NG, Iliadi KG, Bragina JV, Heisenberg M, et al. Age-dependent changes in memory and mushroom bodies in the Drosophila mutant vermilion deficient in the kynurenine pathway of tryptophan metabolism. Ross Fiziol Zh Im I M Sechenova (1999) 85:167-83.
104. Savvateeva E, Popov A, Kamyshev N, Bragina J, Heisenberg M, Senitz D, et al. Age-dependent memory loss, synaptic pathology and altered brain plasticity in the Drosophila mutant cardinal accumulating 3-hydroxykynurenine. J Neural Transm (2000) 1996(107):581-601. doi:10.1007/s007020070080
105. Powell-Coffman JA, Qin H. Invertebrate AHR homologs: ancestral functions in sensory systems. In: Pohjanvirta R, editor. The AH Receptor in Biology and Toxicology. Hoboken, NJ: John Wiley & Sons, Inc (2011). p. 405-11.